Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / Fund iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer Blackrock
Entity holding fund iShares Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF Ticker IDUS(USD) LSE
ETF Ticker IDUS.LS(USD) CXE
ETF Ticker IUSA.AS(EUR) CXE
ETF Ticker IUSA.DE(EUR) CXE
ETF Ticker IUSA.LS(GBX) CXE
ETF Ticker IUSA.MI(EUR) CXE
ETF Ticker IUSAz(USD) CXE
ETF Ticker IUSA(EUR) ETF Plus
ETF Ticker IDUS.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Core S&P 500 UCITS ETF USD (Dist) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-15 (Monday)	35,332	USD 26,591,570	USD 26,591,570	-14	USD 389,934	USD 752.62	USD 741.29
2025-12-12 (Friday)	35,346	USD 26,201,636	USD 26,201,636	0	USD 1,721,703	USD 741.29	USD 692.58
2025-12-09 (Tuesday)	35,346	USD 24,479,933	USD 24,479,933	0	USD -377,495	USD 692.58	USD 703.26
2025-12-08 (Monday)	35,346	USD 24,857,428	USD 24,857,428	0	USD -533,725	USD 703.26	USD 718.36
2025-12-05 (Friday)	35,346	USD 25,391,153	USD 25,391,153	14	USD -146,817	USD 718.36	USD 722.8
2025-12-04 (Thursday)	35,332	USD 25,537,970	USD 25,537,970	0	USD -30,738	USD 722.8	USD 723.67
2025-12-03 (Wednesday)	35,332	USD 25,568,708	USD 25,568,708	0	USD -647,636	USD 723.67	USD 742
2025-12-02 (Tuesday)	35,332	USD 26,216,344	USD 26,216,344	0	USD -286,543	USD 742	USD 750.11
2025-12-01 (Monday)	35,332	USD 26,502,887	USD 26,502,887	-14	USD -1,325,726	USD 750.11	USD 787.32

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE0031442068

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-15 SELL -14 756.660 746.375 747.403 USD -10,464 652.24 Loss of -1,332 on sale
2025-12-05 BUY 14 736.150 717.265 719.153 USD 10,068 651.17
2025-12-01 SELL -14 779.840 748.210 751.373 USD -10,519 649.70 Loss of -1,423 on sale
2025-11-25 SELL -126 790.570 760.700 763.687 USD -96,225 649.09 Loss of -14,439 on sale
2025-11-21 SELL -14 755.900* 648.11 Profit of 9,074 on sale
2025-11-19 SELL -28 702.750* 647.46 Profit of 18,129 on sale
2025-11-18 SELL -42 725.340* 647.11 Profit of 27,179 on sale
2025-11-17 SELL -56 711.880 692.290 694.249 USD -38,878 646.85 Loss of -2,654 on sale
2025-11-13 SELL -112 713.580 679.930 683.295 USD -76,529 646.63 Loss of -4,106 on sale
2025-11-11 SELL -28 676.330 651.410 653.902 USD -18,309 646.50 Loss of -207 on sale
2025-11-10 SELL -84 665.990 653.190 654.470 USD -54,975 646.47 Loss of -672 on sale
2025-11-06 SELL -28 657.000 641.260 642.834 USD -17,999 646.46 Profit of 102 on sale
2025-11-04 SELL -56 646.221 625.140 627.248 USD -35,126 646.55 Profit of 1,081 on sale
2025-10-22 SELL -14 584.740 588.710 588.313 USD -8,236 646.84 Profit of 819 on sale
2025-10-21 SELL -28 579.340 582.410 582.103 USD -16,299 647.15 Profit of 1,821 on sale
2025-10-16 BUY 14 569.170 589.080 587.089 USD 8,219 647.52
2025-10-14 SELL -42 572.600 576.180 575.822 USD -24,185 648.22 Profit of 3,041 on sale
2025-10-13 SELL -56 557.730 563.770 563.166 USD -31,537 648.65 Profit of 4,787 on sale
2025-09-25 BUY 14 555.510 579.000 576.651 USD 8,073 650.43
2025-09-24 SELL -848 576.980 577.980 577.880 USD -490,042 650.79 Profit of 61,830 on sale
2025-09-18 BUY 14 598.710 600.000 599.871 USD 8,398 651.05
2025-09-17 BUY 14 585.500 587.670 587.453 USD 8,224 651.38
2025-08-19 SELL -28 571.780 581.690 580.699 USD -16,260 652.74 Profit of 2,017 on sale
2025-08-15 SELL -14 580.410 581.950 581.796 USD -8,145 653.52 Profit of 1,004 on sale
2025-08-13 SELL -70 561.550 565.500 565.105 USD -39,557 653.99 Profit of 6,222 on sale
2025-08-12 SELL -182 556.550 562.740 562.121 USD -102,306 654.50 Profit of 16,813 on sale
2025-08-07 SELL -210 559.800 565.480 564.912 USD -118,632 654.99 Profit of 18,917 on sale
2025-08-05 BUY 14 569.900 579.820 578.828 USD 8,104 655.97
2025-07-31 BUY 42 545.460 558.130 556.863 USD 23,388 656.55
2025-07-28 BUY 14 558.630 567.950 567.018 USD 7,938 658.15
2025-07-25 SELL -28 563.100 567.210 566.799 USD -15,870 658.67 Profit of 2,572 on sale
2025-07-24 BUY 14 564.640 577.730 576.421 USD 8,070 659.18
2025-07-18 BUY 14 542.520 550.890 550.053 USD 7,701 661.49
2025-07-14 SELL -14 570.590 575.130 574.676 USD -8,045 663.93 Profit of 1,250 on sale
2025-07-08 SELL -28 547.750 559.460 558.289 USD -15,632 665.84 Profit of 3,012 on sale
2025-07-02 BUY 84 547.740 551.500 551.124 USD 46,294 668.70
2025-06-24 SELL -28 522.270 527.450 526.932 USD -14,754 673.18 Profit of 4,095 on sale
2025-06-23 SELL -14 511.920 516.180 515.754 USD -7,221 674.17 Profit of 2,218 on sale
2025-06-20 SELL -473 509.720 521.310 520.151 USD -246,031 675.18 Profit of 73,329 on sale
2025-06-12 SELL -42 521.840 525.220 524.882 USD -22,045 679.25 Profit of 6,483 on sale
2025-06-06 BUY 14 493.220 499.880 499.214 USD 6,989 683.56
2025-06-02 SELL -42 490.810 502.560 501.385 USD -21,058 688.81 Profit of 7,872 on sale
2025-05-29 SELL -14 605.390 605.730 605.696 USD -8,480 690.72 Profit of 1,190 on sale
2025-05-27 BUY 14 603.260 608.170 607.679 USD 8,508 691.99
2025-05-23 BUY 14 588.340 591.640 591.310 USD 8,278 693.43
2025-05-21 SELL -42 604.620 617.520 616.230 USD -25,882 694.74 Profit of 3,297 on sale
2025-05-15 BUY 56 584.990 585.260 585.233 USD 32,773 697.55
2025-05-14 SELL -84 571.360 580.560 579.640 USD -48,690 698.47 Profit of 9,982 on sale
2025-05-13 SELL -168 574.160 575.050 574.961 USD -96,593 699.39 Profit of 20,904 on sale
2025-05-07 SELL -42 560.930 568.130 567.410 USD -23,831 703.82 Profit of 5,729 on sale
2025-05-02 SELL -14 605.610 615.610 614.610 USD -8,605 706.49 Profit of 1,286 on sale
2025-04-29 SELL -42 568.910 579.980 578.873 USD -24,313 709.36 Profit of 5,480 on sale
2025-04-24 BUY 14 599.760 601.280 601.128 USD 8,416 711.92
2025-04-22 BUY 56 585.490 587.100 586.939 USD 32,869 713.99
2025-04-16 BUY 14 549.280 561.830 560.575 USD 7,848 719.28
2025-04-15 BUY 14 557.910 575.200 573.471 USD 8,029 720.67
2025-04-11 BUY 28 554.180 555.530 555.395 USD 15,551 723.44
2025-04-09 BUY 70 576.720 580.730 580.329 USD 40,623 726.33
2025-04-08 BUY 210 556.810 586.030 583.108 USD 122,453 727.86
2025-04-07 SELL -98 572.780 591.540 589.664 USD -57,787 729.27 Profit of 13,681 on sale
2025-04-04 SELL -210 573.450 612.990 609.036 USD -127,898 730.70 Profit of 25,549 on sale
2025-04-02 SELL -42 625.600 628.000 627.760 USD -26,366 731.67 Profit of 4,364 on sale
2025-04-01 SELL -14 617.000 641.240 638.816 USD -8,943 732.74 Profit of 1,315 on sale
2025-03-31 SELL -28 634.230 640.720 640.071 USD -17,922 733.67 Profit of 2,621 on sale
2025-03-28 BUY 28 637.360 642.970 642.409 USD 17,987 734.59
2025-03-25 BUY 42 634.140 662.570 659.727 USD 27,709 737.47
2025-03-24 BUY 56 661.000 667.460 666.814 USD 37,342 738.23
2025-03-21 SELL -28 658.480 661.000 660.748 USD -18,501 739.02 Profit of 2,192 on sale
2025-03-20 BUY 28 662.620 674.830 673.609 USD 18,861 739.80
2025-03-19 BUY 56 672.360 674.570 674.349 USD 37,764 740.48
2025-03-17 SELL -42 678.420 679.830 679.689 USD -28,547 741.92 Profit of 2,614 on sale
2025-03-14 SELL -28 666.870 686.980 684.969 USD -19,179 742.71 Profit of 1,617 on sale
2025-03-13 SELL -84 680.610 698.950 697.116 USD -58,558 743.37 Profit of 3,885 on sale
2025-03-12 SELL -121 689.500 712.460 710.164 USD -85,930 743.95 Profit of 4,088 on sale
2025-03-11 SELL -98 718.160 747.700 744.746 USD -72,985 744.23 Loss of -51 on sale
2025-03-10 SELL -56 744.830 748.290 747.944 USD -41,885 744.22 Loss of -208 on sale
2025-03-06 SELL -56 698.440 701.000 700.744 USD -39,242 745.15 Profit of 2,487 on sale
2025-03-05 SELL -84 687.150 692.790 692.226 USD -58,147 745.81 Profit of 4,501 on sale
2025-03-04 SELL -112 675.490 697.460 695.263 USD -77,869 746.62 Profit of 5,752 on sale
2025-02-28 SELL -70 698.740 708.580 707.596 USD -49,532 747.91 Profit of 2,822 on sale
2025-02-26 BUY 28 706.940 721.410 719.963 USD 20,159 748.94
2025-02-24 BUY 28 713.250 725.000 723.825 USD 20,267 749.70
2025-02-21 BUY 14 700.330 704.080 703.705 USD 9,852 750.31
2025-02-20 SELL -42 696.020 703.140 702.428 USD -29,502 751.00 Profit of 2,040 on sale
2025-02-14 SELL -14 673.600 684.000 682.960 USD -9,561 754.88 Profit of 1,007 on sale
2025-02-13 SELL -182 674.270 677.690 677.348 USD -123,277 755.97 Profit of 14,310 on sale
2025-02-12 SELL -14 663.860 670.980 670.268 USD -9,384 757.24 Profit of 1,218 on sale
2025-02-06 SELL -56 722.070 734.270 733.050 USD -41,051 760.73 Profit of 1,550 on sale
2025-02-05 BUY 14 716.720 729.250 727.997 USD 10,192 761.38
2025-02-04 BUY 98 697.050 709.980 708.687 USD 69,451 762.34
2025-01-29 SELL -98 687.270 697.570 696.540 USD -68,261 767.72 Profit of 6,976 on sale
2025-01-28 BUY 28 686.330 690.300 689.903 USD 19,317 769.03
2025-01-24 BUY 14 675.790 693.840 692.035 USD 9,688 771.99
2025-01-22 BUY 28 680.030 699.880 697.895 USD 19,541 774.91
2025-01-16 BUY 28 693.230 706.540 705.209 USD 19,746 781.49
2025-01-15 BUY 14 703.430 712.600 711.683 USD 9,964 782.97
2025-01-10 BUY 28 696.880 724.730 721.945 USD 20,214 787.85
2025-01-02 BUY 42 715.190 726.810 725.648 USD 30,477 791.71
2024-12-31 BUY 28 712.330 713.000 712.933 USD 19,962 793.43
2024-12-27 BUY 14 712.400 718.990 718.331 USD 10,057 797.34
2024-12-20 SELL -340 701.850 717.610 716.034 USD -243,452 805.87 Profit of 30,544 on sale
2024-12-19 BUY 14 708.250 714.050 713.470 USD 9,989 808.37
2024-12-18 SELL -14 714.620 745.000 741.962 USD -10,387 810.84 Profit of 964 on sale
2024-12-17 BUY 28 740.010 744.800 744.321 USD 20,841 812.75
2024-12-13 BUY 14 731.300 740.170 739.283 USD 10,350 817.59
2024-12-10 BUY 14 778.500 791.490 790.191 USD 11,063 820.13
2024-12-06 SELL -28 778.000 778.120 778.108 USD -21,787 822.52 Profit of 1,244 on sale
2024-12-05 BUY 14 767.900 768.020 768.008 USD 10,752 824.34
2024-12-04 SELL -112 754.260 756.130 755.943 USD -84,666 826.76 Profit of 7,932 on sale
2024-12-03 BUY 42 749.570 770.000 767.957 USD 32,254 829.52
2024-12-02 BUY 70 762.340 763.890 763.735 USD 53,461 832.00
2024-11-27 BUY 14 754.870 762.160 761.431 USD 10,660 841.84
2024-11-26 BUY 98 753.030 754.180 754.065 USD 73,898 845.70
2024-11-21 BUY 42 744.500 757.560 756.254 USD 31,763 860.96
2024-11-20 BUY 28 743.350 750.690 749.956 USD 20,999 867.15
2024-11-19 BUY 14 744.600 758.600 757.200 USD 10,601 873.95
2024-11-18 BUY 28 762.000 762.700 762.630 USD 21,354 880.54
2024-11-12 BUY 56 821.000 831.000 830.000 USD 46,480 884.26
2024-11-11 BUY 28 825.680 834.420 833.546 USD 23,339 888.17
2024-11-08 BUY 112 828.420 830.730 830.499 USD 93,016 892.43
2024-11-07 BUY 98 824.480 832.530 831.725 USD 81,509 897.66
2024-11-06 BUY 112 816.650 844.510 841.724 USD 94,273 904.41
2024-11-05 SELL -28 829.430 836.630 835.910 USD -23,405 911.23 Profit of 2,109 on sale
2024-11-04 BUY 28 828.840 852.010 849.693 USD 23,791 919.47
2024-11-01 BUY 98 843.600 862.000 860.160 USD 84,296 927.90
2024-10-28 BUY 70 928.610 943.270 941.804 USD 65,926 946.83
2024-10-25 BUY 154 933.020 943.830 942.749 USD 145,183 950.28
2024-10-23 SELL -14 941.390 959.600 957.779 USD -13,409 965.42 Profit of 107 on sale
2024-10-21 BUY 14 968.500 991.240 988.966 USD 13,846 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-15	SELL	-14	756.660	746.375	747.403	USD -10,464	652.24 Loss of -1,332 on sale
2025-12-05	BUY	14	736.150	717.265	719.153	USD 10,068	651.17
2025-12-01	SELL	-14	779.840	748.210	751.373	USD -10,519	649.70 Loss of -1,423 on sale
2025-11-25	SELL	-126	790.570	760.700	763.687	USD -96,225	649.09 Loss of -14,439 on sale
2025-11-21	SELL	-14			755.900*		648.11 Profit of 9,074 on sale
2025-11-19	SELL	-28			702.750*		647.46 Profit of 18,129 on sale
2025-11-18	SELL	-42			725.340*		647.11 Profit of 27,179 on sale
2025-11-17	SELL	-56	711.880	692.290	694.249	USD -38,878	646.85 Loss of -2,654 on sale
2025-11-13	SELL	-112	713.580	679.930	683.295	USD -76,529	646.63 Loss of -4,106 on sale
2025-11-11	SELL	-28	676.330	651.410	653.902	USD -18,309	646.50 Loss of -207 on sale
2025-11-10	SELL	-84	665.990	653.190	654.470	USD -54,975	646.47 Loss of -672 on sale
2025-11-06	SELL	-28	657.000	641.260	642.834	USD -17,999	646.46 Profit of 102 on sale
2025-11-04	SELL	-56	646.221	625.140	627.248	USD -35,126	646.55 Profit of 1,081 on sale
2025-10-22	SELL	-14	584.740	588.710	588.313	USD -8,236	646.84 Profit of 819 on sale
2025-10-21	SELL	-28	579.340	582.410	582.103	USD -16,299	647.15 Profit of 1,821 on sale
2025-10-16	BUY	14	569.170	589.080	587.089	USD 8,219	647.52
2025-10-14	SELL	-42	572.600	576.180	575.822	USD -24,185	648.22 Profit of 3,041 on sale
2025-10-13	SELL	-56	557.730	563.770	563.166	USD -31,537	648.65 Profit of 4,787 on sale
2025-09-25	BUY	14	555.510	579.000	576.651	USD 8,073	650.43
2025-09-24	SELL	-848	576.980	577.980	577.880	USD -490,042	650.79 Profit of 61,830 on sale
2025-09-18	BUY	14	598.710	600.000	599.871	USD 8,398	651.05
2025-09-17	BUY	14	585.500	587.670	587.453	USD 8,224	651.38
2025-08-19	SELL	-28	571.780	581.690	580.699	USD -16,260	652.74 Profit of 2,017 on sale
2025-08-15	SELL	-14	580.410	581.950	581.796	USD -8,145	653.52 Profit of 1,004 on sale
2025-08-13	SELL	-70	561.550	565.500	565.105	USD -39,557	653.99 Profit of 6,222 on sale
2025-08-12	SELL	-182	556.550	562.740	562.121	USD -102,306	654.50 Profit of 16,813 on sale
2025-08-07	SELL	-210	559.800	565.480	564.912	USD -118,632	654.99 Profit of 18,917 on sale
2025-08-05	BUY	14	569.900	579.820	578.828	USD 8,104	655.97
2025-07-31	BUY	42	545.460	558.130	556.863	USD 23,388	656.55
2025-07-28	BUY	14	558.630	567.950	567.018	USD 7,938	658.15
2025-07-25	SELL	-28	563.100	567.210	566.799	USD -15,870	658.67 Profit of 2,572 on sale
2025-07-24	BUY	14	564.640	577.730	576.421	USD 8,070	659.18
2025-07-18	BUY	14	542.520	550.890	550.053	USD 7,701	661.49
2025-07-14	SELL	-14	570.590	575.130	574.676	USD -8,045	663.93 Profit of 1,250 on sale
2025-07-08	SELL	-28	547.750	559.460	558.289	USD -15,632	665.84 Profit of 3,012 on sale
2025-07-02	BUY	84	547.740	551.500	551.124	USD 46,294	668.70
2025-06-24	SELL	-28	522.270	527.450	526.932	USD -14,754	673.18 Profit of 4,095 on sale
2025-06-23	SELL	-14	511.920	516.180	515.754	USD -7,221	674.17 Profit of 2,218 on sale
2025-06-20	SELL	-473	509.720	521.310	520.151	USD -246,031	675.18 Profit of 73,329 on sale
2025-06-12	SELL	-42	521.840	525.220	524.882	USD -22,045	679.25 Profit of 6,483 on sale
2025-06-06	BUY	14	493.220	499.880	499.214	USD 6,989	683.56
2025-06-02	SELL	-42	490.810	502.560	501.385	USD -21,058	688.81 Profit of 7,872 on sale
2025-05-29	SELL	-14	605.390	605.730	605.696	USD -8,480	690.72 Profit of 1,190 on sale
2025-05-27	BUY	14	603.260	608.170	607.679	USD 8,508	691.99
2025-05-23	BUY	14	588.340	591.640	591.310	USD 8,278	693.43
2025-05-21	SELL	-42	604.620	617.520	616.230	USD -25,882	694.74 Profit of 3,297 on sale
2025-05-15	BUY	56	584.990	585.260	585.233	USD 32,773	697.55
2025-05-14	SELL	-84	571.360	580.560	579.640	USD -48,690	698.47 Profit of 9,982 on sale
2025-05-13	SELL	-168	574.160	575.050	574.961	USD -96,593	699.39 Profit of 20,904 on sale
2025-05-07	SELL	-42	560.930	568.130	567.410	USD -23,831	703.82 Profit of 5,729 on sale
2025-05-02	SELL	-14	605.610	615.610	614.610	USD -8,605	706.49 Profit of 1,286 on sale
2025-04-29	SELL	-42	568.910	579.980	578.873	USD -24,313	709.36 Profit of 5,480 on sale
2025-04-24	BUY	14	599.760	601.280	601.128	USD 8,416	711.92
2025-04-22	BUY	56	585.490	587.100	586.939	USD 32,869	713.99
2025-04-16	BUY	14	549.280	561.830	560.575	USD 7,848	719.28
2025-04-15	BUY	14	557.910	575.200	573.471	USD 8,029	720.67
2025-04-11	BUY	28	554.180	555.530	555.395	USD 15,551	723.44
2025-04-09	BUY	70	576.720	580.730	580.329	USD 40,623	726.33
2025-04-08	BUY	210	556.810	586.030	583.108	USD 122,453	727.86
2025-04-07	SELL	-98	572.780	591.540	589.664	USD -57,787	729.27 Profit of 13,681 on sale
2025-04-04	SELL	-210	573.450	612.990	609.036	USD -127,898	730.70 Profit of 25,549 on sale
2025-04-02	SELL	-42	625.600	628.000	627.760	USD -26,366	731.67 Profit of 4,364 on sale
2025-04-01	SELL	-14	617.000	641.240	638.816	USD -8,943	732.74 Profit of 1,315 on sale
2025-03-31	SELL	-28	634.230	640.720	640.071	USD -17,922	733.67 Profit of 2,621 on sale
2025-03-28	BUY	28	637.360	642.970	642.409	USD 17,987	734.59
2025-03-25	BUY	42	634.140	662.570	659.727	USD 27,709	737.47
2025-03-24	BUY	56	661.000	667.460	666.814	USD 37,342	738.23
2025-03-21	SELL	-28	658.480	661.000	660.748	USD -18,501	739.02 Profit of 2,192 on sale
2025-03-20	BUY	28	662.620	674.830	673.609	USD 18,861	739.80
2025-03-19	BUY	56	672.360	674.570	674.349	USD 37,764	740.48
2025-03-17	SELL	-42	678.420	679.830	679.689	USD -28,547	741.92 Profit of 2,614 on sale
2025-03-14	SELL	-28	666.870	686.980	684.969	USD -19,179	742.71 Profit of 1,617 on sale
2025-03-13	SELL	-84	680.610	698.950	697.116	USD -58,558	743.37 Profit of 3,885 on sale
2025-03-12	SELL	-121	689.500	712.460	710.164	USD -85,930	743.95 Profit of 4,088 on sale
2025-03-11	SELL	-98	718.160	747.700	744.746	USD -72,985	744.23 Loss of -51 on sale
2025-03-10	SELL	-56	744.830	748.290	747.944	USD -41,885	744.22 Loss of -208 on sale
2025-03-06	SELL	-56	698.440	701.000	700.744	USD -39,242	745.15 Profit of 2,487 on sale
2025-03-05	SELL	-84	687.150	692.790	692.226	USD -58,147	745.81 Profit of 4,501 on sale
2025-03-04	SELL	-112	675.490	697.460	695.263	USD -77,869	746.62 Profit of 5,752 on sale
2025-02-28	SELL	-70	698.740	708.580	707.596	USD -49,532	747.91 Profit of 2,822 on sale
2025-02-26	BUY	28	706.940	721.410	719.963	USD 20,159	748.94
2025-02-24	BUY	28	713.250	725.000	723.825	USD 20,267	749.70
2025-02-21	BUY	14	700.330	704.080	703.705	USD 9,852	750.31
2025-02-20	SELL	-42	696.020	703.140	702.428	USD -29,502	751.00 Profit of 2,040 on sale
2025-02-14	SELL	-14	673.600	684.000	682.960	USD -9,561	754.88 Profit of 1,007 on sale
2025-02-13	SELL	-182	674.270	677.690	677.348	USD -123,277	755.97 Profit of 14,310 on sale
2025-02-12	SELL	-14	663.860	670.980	670.268	USD -9,384	757.24 Profit of 1,218 on sale
2025-02-06	SELL	-56	722.070	734.270	733.050	USD -41,051	760.73 Profit of 1,550 on sale
2025-02-05	BUY	14	716.720	729.250	727.997	USD 10,192	761.38
2025-02-04	BUY	98	697.050	709.980	708.687	USD 69,451	762.34
2025-01-29	SELL	-98	687.270	697.570	696.540	USD -68,261	767.72 Profit of 6,976 on sale
2025-01-28	BUY	28	686.330	690.300	689.903	USD 19,317	769.03
2025-01-24	BUY	14	675.790	693.840	692.035	USD 9,688	771.99
2025-01-22	BUY	28	680.030	699.880	697.895	USD 19,541	774.91
2025-01-16	BUY	28	693.230	706.540	705.209	USD 19,746	781.49
2025-01-15	BUY	14	703.430	712.600	711.683	USD 9,964	782.97
2025-01-10	BUY	28	696.880	724.730	721.945	USD 20,214	787.85
2025-01-02	BUY	42	715.190	726.810	725.648	USD 30,477	791.71
2024-12-31	BUY	28	712.330	713.000	712.933	USD 19,962	793.43
2024-12-27	BUY	14	712.400	718.990	718.331	USD 10,057	797.34
2024-12-20	SELL	-340	701.850	717.610	716.034	USD -243,452	805.87 Profit of 30,544 on sale
2024-12-19	BUY	14	708.250	714.050	713.470	USD 9,989	808.37
2024-12-18	SELL	-14	714.620	745.000	741.962	USD -10,387	810.84 Profit of 964 on sale
2024-12-17	BUY	28	740.010	744.800	744.321	USD 20,841	812.75
2024-12-13	BUY	14	731.300	740.170	739.283	USD 10,350	817.59
2024-12-10	BUY	14	778.500	791.490	790.191	USD 11,063	820.13
2024-12-06	SELL	-28	778.000	778.120	778.108	USD -21,787	822.52 Profit of 1,244 on sale
2024-12-05	BUY	14	767.900	768.020	768.008	USD 10,752	824.34
2024-12-04	SELL	-112	754.260	756.130	755.943	USD -84,666	826.76 Profit of 7,932 on sale
2024-12-03	BUY	42	749.570	770.000	767.957	USD 32,254	829.52
2024-12-02	BUY	70	762.340	763.890	763.735	USD 53,461	832.00
2024-11-27	BUY	14	754.870	762.160	761.431	USD 10,660	841.84
2024-11-26	BUY	98	753.030	754.180	754.065	USD 73,898	845.70
2024-11-21	BUY	42	744.500	757.560	756.254	USD 31,763	860.96
2024-11-20	BUY	28	743.350	750.690	749.956	USD 20,999	867.15
2024-11-19	BUY	14	744.600	758.600	757.200	USD 10,601	873.95
2024-11-18	BUY	28	762.000	762.700	762.630	USD 21,354	880.54
2024-11-12	BUY	56	821.000	831.000	830.000	USD 46,480	884.26
2024-11-11	BUY	28	825.680	834.420	833.546	USD 23,339	888.17
2024-11-08	BUY	112	828.420	830.730	830.499	USD 93,016	892.43
2024-11-07	BUY	98	824.480	832.530	831.725	USD 81,509	897.66
2024-11-06	BUY	112	816.650	844.510	841.724	USD 94,273	904.41
2024-11-05	SELL	-28	829.430	836.630	835.910	USD -23,405	911.23 Profit of 2,109 on sale
2024-11-04	BUY	28	828.840	852.010	849.693	USD 23,791	919.47
2024-11-01	BUY	98	843.600	862.000	860.160	USD 84,296	927.90
2024-10-28	BUY	70	928.610	943.270	941.804	USD 65,926	946.83
2024-10-25	BUY	154	933.020	943.830	942.749	USD 145,183	950.28
2024-10-23	SELL	-14	941.390	959.600	957.779	USD -13,409	965.42 Profit of 107 on sale
2024-10-21	BUY	14	968.500	991.240	988.966	USD 13,846	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDUS(USD) LSE
ETF Ticker	IDUS.LS(USD) CXE
ETF Ticker	IUSA.AS(EUR) CXE
ETF Ticker	IUSA.DE(EUR) CXE
ETF Ticker	IUSA.LS(GBX) CXE
ETF Ticker	IUSA.MI(EUR) CXE
ETF Ticker	IUSAz(USD) CXE
ETF Ticker	IUSA(EUR) ETF Plus
ETF Ticker	IDUS.L(GBP) LSE